AGER and prostate cancer: Moreover, in 343 prostate cancer patients with no grade group upgrade, the RAGE rs1800625 polymorphic variants ‘TC + CC’ were also found to be associated with perineural invasion (p = 0.014) and biochemical recurrence (p = 0.039) (Table 5).